Western blot analysis of 100000g supernatant of rat retina using a polyclonal anti-Ca2+/ calmodulin-dependent protein kinase IV (CaM-kinase IV) antibody revealed an immunoreactive mass of 35 kDa, termed reticalmin. Lower amount of a isoform of CaM-kinase IV was also expressed in rat retina. Reticalmin did not react with anti-CaM-kinase IV C-terminal peptide antibody which recognized g and fl isoforms of CaM-kinase IV and calspermin. Immunohistochemically reticaimin was shown to be localized mainly in the outer segment of photo-receptor cells, and in dendrites of inner plexiform layers and may be in nuclei of ganglion cells and some inner nuclear layer cells. © 1997 Elsevier Science Ltd.
INTRODUCTION
Ca2+/calmodulin-dependent protein kinase IV (CAMkinase IV), also known as CaM-kinase Gr (Ohmstede et al., 1989) , is a multifunctional Ca2+/calmodulin-dependent protein kinase. It is expressed abundantly in the brain with particularly high levels in cerebellar granule cells, has moderate levels in thymus and T cells, and much lower levels in non-neuronal tissues such as liver, spleen, kidney, lung, heart, and skeletal muscle (Frangakis et al., 1991; Miyano et al., 1992; Nakamura et al., 1995) . CaM-kinase IV is thought to play important roles in the central nervous system and in the immune system. The purified preparation of CaM-kinase IV from rat cerebellum gave two protein bands with apparent molecular weights (Mr) of 63 kDa (~) and 66 kDa (/6) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the characteristic properties and the distribution of these enzymes (especially those of the ~t isoform) have been extensively studied (Cruzalegui & Means, 1993; Okuno et al., 1994; Kitani et al., 1995) .
CaM-kinase IV has been cloned and a high sequence
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homology with the catalytic and regulatory domains of CaM-kinase II has been elucidated (Sikela & Hahn, 1987; Kitani et al., 1994; Jones et al., 1991) . Autophosphorylation of CaM-kinase IV was shown to activate its enzymatic activity, but the rate was slow and the maximal activation was only 1.5-fold (Cruzalegui & Means, 1993) . Phosphorylation on a threonine residue (Thr 196) in the "activation loop" by CaM-kinase IV 2+ kinase, another Ca /calmodulin-dependent protein kinase, was shown to be important for full activity (Selbert et al., 1995) .
Recently a 42-kb pair region of rat DNA containing the CaM-kinase IV gene was cloned (Sun et al., 1995) . The CaM-kinase IV gene was shown to consist of 12 exons and 11 introns, and was predicted to encode the ~t and fl isoforms of CaM-kinase IV and calspermin, a testis specific CaM-binding protein (Sun et al., 1995) .
CaM-kinase IV was recently demonstrated to be present in the ganglion cell layer (GCL) and outer half of the inner nuclear layer (INL) of rat retina by the immunohistochemical staining in connection with the distribution of c-AMP responsive element (CREB) and calmodulin-kinase II (CaM-kinase II) (Yoshida et al., 1996; Terashima et al., 1994) .
In the present study, we have immunochemically demonstrated the existence of a novel CaM-kinase IV like peptide in rat retina and its possible distribution in retina. This novel protein was named "reticalmin" and was compared with CaM-kinase IV and calspermin. 2029 FIGURE 1. Western blot analysis of rat retina using anti-CaM-kinase IV antibodies. Antibodies against recombinant rat brain CaM-kinase IV (A), C-terminal peptide of CaM-kinase IV (B) and the neutralized antibody against recombinant rat brain CaMkinase IV (C) were used as the first antibodies for Western blot analysis as described in. Molecular weights are given on the left in kDa. (A) 1, Cerebellum; 2, retina; 3, retina + testis; 4, testis. (B) 1, Cerebellum; 2, retina; 3, testis. (C) 1, Cerebellum; 2, retina.
METHODS

Materials
Protease inhibitors, leupeptin, antipain, chymostatin, and pepstatin, were purchased from the Peptide Institute (Osaka, Japan). Other chemicals were of the highest grade commercially available. Rabbit polyclonal antibodies to CaM-kinase IV were prepared by immunization with recombinant rat brain enzyme expressed in Escherichia coli (Okuno & Fujisawa, 1993) . Rabbit polyclonal antibodies against C-terminal peptides (465-474) of the rat CaM-kinase IV (sequence= PQQDAILPEY) were purchased from Upstate Biotech. Inc. [New York, U.S.A., see Means et al. (1991) ].
Isolation of rat retinas
Male Sprague-Dawley rats fed ad libitium were anesthetized by intraperitoneal injection of Nembutal (40-50 mg/kg). Ten weeks old rat eyes were dissected and washed with ice cold phosphate buffered saline (PBS) and keratectomy was performed. After lenses and vitreous bodies were extirpated from eye balls, retinas were obtained en bloc, and immediately immersed into liquid nitrogen and then stored at -80°C. Cerebellum and testes were also isolated from the same animals.
Western blot analysis
Western blot analysis was carried out by the method of Towbin et al. (1985) . Isolated retinas as well as cerebellar and testicular tissues were homogenized in five volumes of the homogenization buffer containing 20 mM HEPES, 5% Triton X-100, 100 mM dithiothreitol (DTF), 20 #g/ ml leupeptin, 20 pg/ml antipain, 20 #g/ml chymostatin, 20 #g/ml pepstatin using a Polytron homogenizer with three 30-sec bursts (interval time, 15 sec). After centrifugation at 8000g for 10 rain, the supernatant was centrifuged at 100 000g for 60 min. All procedures were performed at 4°C. Fifty micrograms of the supernatant proteins from retinas, cerebellum and testes were analyzed by SDS-PAGE under reducing conditions (Laemmli, 1970) . After electrophoretic transfer of proteins from the gels onto nitrocellulose membranes, they were incubated overnight at room temperature with two different anti-CaM-kinase IV polyclonal antibodies (1:10000 dilution for anti-recombinant rat brain CaMkinase IV antibody, 1 #g/ml for anti-CaM-kinase IV Cterminal peptides antibody). To neutralize antibodies with the antigen, an excess amount of recombinant CaMkinase IV (0.2 pg CaM-kinase IV/#I antibody solution) expressed in E. coli was added to the two anti-CaMkinase IV polyclonal antibodies. Membranes were washed three times with Tris-buffered saline and were incubated with horse radish peroxidase-conjugated antirabbit IgG for 2 hr at room temperature. Color development was done using 4-chloro-l-naphthol as a chromogenic substrate for the peroxidase reaction.
Immunohistochemistry
Rats were perfused intracardially with PBS, followed by perfusion with 4% paraformaldehyde in PBS. Retinas were removed, embedded in paraffin, and thin sections (5 pm thickness) were cut using a microtome. Polyclonal antibodies against recombinant rat brain CaM-kinase IV (1:2000 dilution) and C-terminal peptide of the rat CaMkinase IV (5 pg/ml) were used for adjacent sections, according to the Vectastain-ABC system immunostaining method (Vector Lab. Inc., Burlingame, U.S.A.), using diaminobenzidine tetrahydrochloride as a substrate for the peroxidase reaction. Sections were counterstained with Mayer's-hematoxylin. Adjacent sections were also stained with the neutralized antibodies (0.2 #g CaMkinase IV/pl antibody solution).
Protein determination
Protein concentrations were determined by the method of Bradford (1976) using bovine serum albumin as a standard.
RESULTS
Western blot analysis of rat retina using a polyclonal antibody against recombinant rat brain CaM-kinase IV revealed one major immunoreactive band with Mr of 35 kDa and a minor one with Mr of 63 kDa [ Fig. I(A , were also detected on the same membrane. The major molecular mass of retina was clearly different from the two isoforms of CaM-kinase IV and calspermin. We named the major band reticalmin. The minor band could correspond to the ct isoform of CaM-kinase IV according to the identical molecular weight on SDS-PAGE. To determine if reticalmin contains the C-terminal peptide, we performed Western blot analysis of the 100 000g supernatant of retina using a polyclonal antibody against C-terminal peptide (466--474) of rat CaMkinase IV (sequence = PQQDAILPEY). Both ~ and fl isoforms of CaM-kinase IV in cerebellum and calspermin were shown to react to this antibody, whereas reticalmin did not [ Fig. I(B) ].
Anti-CaM-kinase IV antibody used in Fig. I (A) was neutralized by an excess amount of CaM-kinase IV expressed in E. coli and used for Western blot analysis [ Fig. 1(C) ]. No immunoreactive band was observed in either cerebellum or retina 100000g supernatants with the neutralized antibody. Figure 2 shows the immunostaining of 10 weeks old rat retina probed with two anti-CaM-kinase IV polyclonal antibodies. When retina slices were stained with the antibody against recombinant rat brain CaM-kinase IV, the nuclei of some cells of the INL and of most cells in the GCL were positively stained as were dendrites of the inner plexiform layer (IPL) and photoreceptor outer segment [ Fig. 2(A) ]. Positively stained cells in the INL were assumed to be a subset of bipolar cells and horizontal cells based upon their morphological and topological features. Conversely, the immunostaining using the antibody against C-terminal peptide of rat CaM-kinase IV showed a weakly positive reaction in some nuclei and in most of the cytoplasm of GCL cells and in some nuclei of INL cells [ Fig. 2(B) ]. The outer region of the IPL was also weakly stained [ Fig. 2(B) ].
DISCUSSION
CaM-kinase IV was first demonstrated in mouse brain by cDNA cloning by Sikela and Hahn (1987) . The properties of this protein kinase have been extensively studied by several groups (Miyano et al., 1992; Cruzalegui & Means, 1993; Okuno et al., 1994; Kitani et al., 1994 Kitani et al., , 1995 Sikela & Hahn, 1987; Jones et al., 1991; Selbert et al., 1995) . The two isoforms of CaMkinase IV, a (63 kDa) and b (66 kDa), and calspermin (32 kDa) have been reported to be derived from the same gene (Sun et al., 1995) . Recently the presence of CaMkinase IV in the GCL and the outer half of the INL was immunohistochemically demonstrated using antibodies raised against the recombinant CaM-kinase IV (Yoshida et al., 1996) . Western blot analysis using their antibody was not performed in their study, and it is likely that the antibody they used recognized both CaM-kinase IV and reticalmin.
The present study demonstrated that in addition to CaM-kinase IV (Mr 60 kDa) a novel CaM-kinase IV-like protein is present in rat retina with an apparent molecular weight of 35 kDa as shown by Western blot analysis [ Fig.  I(A) ]. We have named this novel protein reticalmin. When the antibody was neutralized with an excess amount of recombinant CaM-kinase IV, both CaM-kinase IV and reticalmin bands disappeared [ Fig. I(C) ]. This indicated that both immunoreactive bands reacted specifically with this antibody. The amount of reticalmin was four to five times more than that of CaM-kinase IV in rat retina as determined by densitometric scanning analysis.
To exclude the possibility that reticalmin may have been derived from CaM-kinase IV by proteolytic digestion during the preparation procedure, we prepared the 100 000g supernatants under two different conditions. In one case, the regular homogenization of quickly frozen rat retinas was performed in the homogenization buffer containing several protease inhibitors. In the second case, the supernatant was prepared using the homogenization buffer without any protease inhibitors but kept for 1 hr at 30°C following centrifugation. Western blot analysis of both preparations showed the same immunoreactive bands with identical intensities indicating that the 35 kDa band (reticalmin) was not a proteolytic fragment of CaM-kinase IV (data not shown).
As shown in Fig. I(A) , reticalmin has a smaller molecular weight than the ~t and fl isoforms of CaMkinase IV and a slightly larger molecular weight than calspermin, a major CaM-binding protein in testis with unknown function (Means et al., 1991; Ono et al., 1989) . We did not detect a positive band corresponding to reticalmin in other rat organs examined including heart, liver, spleen, kidney, and skeletal muscle (data not shown). This 35 kDa band (reticalmin) was also not detected in other tissues examined in the previously published communications (Ohmstede et al., 1989; Frangakis et al., 1991) .
Further evidence that reticalmin is a distinct protein from calspermin was obtained by Western blot analysis [ Fig. I(B) ]. Calspermin has been reported to contain the C-terminal 169 amino acids of CaM-kinase IV. However, when the polyclonal antibody against ten C-terminal amino acids of CaM-kinase IV was used for Western blot analysis, the ~t and fl isoforms of CaM-kinase IV and calspermin were positively stained, but reticalmin was not. This proved that reticalmin did not contain the ten amino acids (PQQDAILPEY) of the C-terminal domain of CaM-kinase IV which a and fl isoforms of CaM-kinase IV and calspermin possess. The immunoreactivity of the 53 kDa band was considered to be nonspecific since this band was also observed at variable levels in the supernatants of heart, liver, spleen, kidney, and skeletal muscle where CaM-kinase IV, reticalmin, and calspermin were not detected. The fact that the 53 kDa band was observed in Western blot analysis using the neutralized anti-CaM-kinase IV C-terminal antibody by an excess amount of recombinant CaM-kinase IV also indicated that this band was a nonspecific product to the C-terminal antibody.
The distribution of CaM-kinase IV in rat retinas has recently been reported immunohistologically using a polyclonal anti-recombinant CaM-kinase IV antibody (Yoshida et al., 1996) . CaM-kinase IV was shown to be distributed in the GCL and the outer part of INL in their study. In addition to the positive staining of the cells in the INL and GCL, we detected equally strong staining in dendrites of the IPL and the outer segment of photoreceptor cells with anti-CaM-kinase IV polyclonal antibody [ Fig. 2(A) ]. In contrast, the antibody against the Cterminal peptide of rat CaM-kinase IV, which reacted to CaM-kinase IV but not to reticalmin, showed weak reactivity only to the nuclei of GCL and INL, and to the outer part of IPL [ Fig. 2(B) ]. Since anti-C-terminal antibodies successfully stained granule cells in rat cerebellum which contain high levels of CaM-kinase IV (Frangakis et al., 1991) at the same dilution (data not shown), the weak signal with this antibody in rat retina could be attributed to the low amount of CaM-kinase IV in retina. Four to five fold more abundant existence of reticalmin than CaM-kinase IV in rat retina and the lack of immunoreactivity of reticalmin to the C-terminal antibody [ Fig. I(B) ] may explain the weaker staining of retina with CaM-kinase IV specific anti-C-terminal antibody [ Fig. 2(B) ] than with anti-recombinant CaMkinase IV antibody which reacts to both CaM-kinase IV and reticalmin [ Fig. 2(A) ]. When the antigen neutralized antibodies against recombinant CaM-kinase IV or preimmune rabbit serum were used, no positive staining was observed (data not shown). Positively stained cells observed in Fig. 2(A) , therefore, included CaM-kinase IV and/or reticalmin containing cells, and those in Fig. 2 (B) more likely indicated CaM-kinase IV containing cells. Further study using a specific antibody which can only react to reticalmin but not to CaM-kinase IV will be necessary.
We have tried to measure the kinase activity in the partially purified fraction of reticalmin using peptide-7 as a substrate. However, no obvious calmodulin-dependent kinase activity was detectable. Cloning of reticalmin using cDNA libraries of human, rat, and bovine retinas is currently being carried out in our laboratory. Mechanisms of expression, intrinsic kinase activity, and physiological roles of reticalmin need to be studied using purified protein or genetically expressed reticalmin in E. coli or insect cells as utilized for the analysis of CaM-kinase IV (Cruzalegui & Means, 1993; Kitani et al., 1994) .
